Molecule Details
| InChIKey | FQYJTHIYAQQJAB-UHFFFAOYSA-N |
|---|---|
| Compound Name | 6-(4-(2-fluorophenyl)-1,3-oxazol-5-yl)-N-(1-methylethyl)-1,3-benzothiazol-2-amine |
| Canonical SMILES | CC(C)Nc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.19 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB08352 |
|---|---|
| Drug Name | 6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine |
| CAS Number | nan |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Cross-references: BindingDB: 50235899 CHEMBL257341 ChemSpider: 22377929 PDB: P41 PubChem:24755476 PubChem:99444823 ZINC: ZINC000016052868
Target Activities (4)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | binder | targets |